Skip to main content
. 2017 Apr 30;8(28):45399–45414. doi: 10.18632/oncotarget.17535

Figure 4. Plasma levels of miR-28-5p, miR-362-5p, and miR-660-5p are reduced in patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer.

Figure 4

The microRNA expression levels in the ALK-positive and ALK-negative non-small cell lung cancer cohorts (x-axis) are shown as 2−ΔΔCt values (y-axis), as calculated from real-time quantitative polymerase chain reaction. Statistically significant p values are indicated as follows: *p < 0.05; **p < 0.01; ***p < 0.001.